Surgical site infections (SSIs) affect 5‑10% of patients in India, prolonging hospital stays and increasing costs. One solution? Sutures coated with triclosan or silver ions. The India surgical sutures market research shows that antimicrobial sutures are growing at over 6% CAGR, driven by hospitals looking to reduce SSI rates. Studies suggest they can cut infection risk by 30‑40%.

How do they work? The coating slowly releases antibacterial agents, killing bacteria that try to travel along the suture track. The India surgical sutures market analysis notes that hospitals are the dominant end‑user segment, but ambulatory surgical centers are adopting them too — because an infection in an outpatient can still lead to hospitalisation.

But there's a debate: some studies show no benefit, especially in clean surgeries. And overuse of antimicrobials could contribute to resistance. That's why guidelines recommend reserving them for high‑risk cases (colorectal, biliary, trauma).

The takeaway: if you're having a high‑risk surgery, ask about antimicrobial sutures. They're not a magic bullet, but they're a useful tool. And they don't cost much more than regular sutures.